○Takeshi Kawarabayashi1,3, Yusuke Seino2, Takumi Nakamura1, Tomoo Harada4, Naoko Nakahata5, Tetsuya Ueda4, Masamitsu Takatama1, Mikio Shoji1 (1.Dementia Center, Geriatrics Research Institute and Hospital, Japan, 2.Department of Neurology, Hirosaki National Hospital, 3.Department of Neurology, Gunma University Graduate School of Medicine, Japan, 4.Bioanalysis Department, LSI Medience Corporation, 5.Department of Speech-Language-Hearing Therapy, Hirosaki University of Health and Welfare)
Session information
Oral Session
[O-43] Oral Session 43 Dementia4
Sat. May 22, 2021 10:15 AM - 11:45 AM Room 07 (ICC Kyoto 1F Room D)
Chair:Ihara Masafumi(National Cerebral and Cardiovascular Center),Makioka Koki(Gunma Uniersity Hospital : Neurology)
○Toshihiko Aso, Takuya Hayashi (Laboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Japan)
○Takayuki Kondo1,2,3, Haruhisa Inoue1,2,3,4 (1.Center for iPS Cell Research and Application, Kyoto University, Japan, 2.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Japan, 3.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Japan, 4.Institute for Advancement of Clinical and Translational Science (iACT) Kyoto University Hospital)
○Tadanori Hamano1, Feiyan Zhu1,2, Gaoping Lin1,3, Ayumu Katsuki1, Nicholas M. Kanaan5, Shu-hui Yen4, Rei Asano1, Hirohito Sasaki1, Tomohisa Yamaguchi1, Soichi Enomoto1, Asako Ueno1, Masamichi Ikawa1, Kouji Hayashi1, Osamu Yamamura1, Masaru Kuriyama6, Yasunari Nakamoto7 (1.Department of Neurology, University of Fukui, Japan, 2.Department of Neurology, Tongde Hospital of Zhejiang Province, 3.Department of Neurology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 4.Department of Neuroscience, Mayo Clinic Jacksonville, 5.Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 6.Brain Attack Ota Memorial Hospital, 7.Department of Gastroenterology, University of Fukui)
○Hiroki Sasaguri1,2, Kenya Sato1,3, Wakako Kumita1,3, Kenichi Nagata1,4, Tetsushi Sakuma5, Takashi Yamamoto5, Takaomi Saido C.1, Erika Sasaki1,3 (1.Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Japan, 2.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 3.Department of Applied Developmental Biology, Central Institute for Experimental Animals, 4.Department of Functional Anatomy and Neuroscience, Nagoya University Graduate School of Medicine, 5.Graduate School of Integrated Sciences for Life, Hiroshima University)
○Jing-cong Zhuang1,2, Ping-ping Cai3, Zhong-jie Chen1, Qing-wei Yang1,2, Xian-jian Wang1, Rong Wang1, Long-ling Li1,2 (1.Department of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China, 2.School of Medicine, Xiamen University, Xiamen, China, 3.Department of Neurology, Fujian Medical University Xiamen Humanity Hospital, Xiamen, China)